Endpoints News 18. Dez. 2025 Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
Endpoints News 18. Dez. 2025 Steve Paul's post-Karuna act draws $165M to schizophrenia biotech Syremis
Endpoints News 17. Dez. 2025 European Commission unveils EU Biotech Act as it lags behind other countries
Endpoints News 17. Dez. 2025 RFK Jr. adds conditions to newborn screening list after committee termination
Endpoints News 17. Dez. 2025 Several companies expected to announce ‘most favored nation’ deals Friday at White House
Endpoints News 17. Dez. 2025 Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail